Research Article

Comparison of the Treatment Efficiency of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl4-Induced Mouse Liver Fibrosis

Table 2

Level of serum markers in groups after 21 days of transplantation.

Group AST ALT Bilirubin Albumin

Control47.15 ± 1.1240.64 ± 2.020.145 ± 0.0211.99 ± 0.057
Model 242.58 ± 12.6412.18 ± 90.64 0.257 ± 0.0221.75 ± 0.042
Placebo-Ta145.6 ± 61.7255 ± 87.3 0.231 ± 0.0321.726 ± 0.096
Placebo-Po218.61 ± 27.71167.83 ± 18.230.315 ± 0.0721.889 ± 0.048
BM-MSCs-Ta132.2 ± 11.8155.8 ± 31.3 0.146 ± 0.0332.11 ± 0.119
BM-MSCs-Po178.42 ± 7.34154.22 ± 6.720.128 ± 0.0302.263 ± 0.126